Mind Medicine Inc’s $19.5 Million Bought Deal Private Placement

Wildeboer Dellelce LLP acted for MindMed.

Mind Medicine (MindMed) Inc. completed a bought deal private placement offering of 6,000,000 units for aggregate gross proceeds of $19,500,000. The offering was conducted by Canaccord Genuity Corp., as underwriter.

MindMed is a psychedelic medicine biotech company that discovers, develops and deploys psychedelic inspired medicines and experiential therapies to address addiction and mental illness.

The Wildeboer Dellelce team included Perry Dellelce (Picture), Peter Volk, Rebecca Cochrane, Sarim Ali and Katie Drury (corporate/securities).

Involved fees earner: Sarim Ali – Wildeboer Dellelce LLP; Rebecca Cochrane – Wildeboer Dellelce LLP; Perry Dellelce – Wildeboer Dellelce LLP; Peter Volk – Wildeboer Dellelce LLP;

Law Firms: Wildeboer Dellelce LLP;

Clients: Mind Medicine Inc;

Martina Bellini

Author: Martina Bellini